My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
The TARGET-D trial presented at AHA 2025 explores how targeted Vitamin D dosing can potentially lower the incidence of recurrent heart attacks among Acute Coronary Syndrome patients. While overall cardiovascular…
29 JUL 2012 Many heart patients make mistakes with their medications after hospital discharge that could lead to clinically important adverse outcomes. Patients who are most vulnerable are the elderly,…
Public release date: 16-May-2011 Study looked at attitudes and prescribing trends of 1,078 family doctors, cardiologists and diabetologists Patients with heart disease risks are more likely to be prescribed cardiovascular…
Aspirin is still overprescribed for stroke prevention in atrial fibrillation despite the potential for dangerous side effects, according to research published today Sophia Antipolis, 28 January 2014: Aspirin is still…
Contact: Jess C. Gomez jess.gomez@imail.org 801-718-8495 Intermountain Medical Center Millions at risk for serious problems like uncontrolled bleeding or developing blood clots SALT LAKE CITY – Cardiology researchers at the…
Public release date: 3-Jul-2007 HOUSTON—(July 3, 2007)—Current PET-CT scanners with standard commercial software designed to provide images of the heart are falsely indicating coronary artery disease in as many as…
You must be logged in to post a comment.